Dawnrays Pharmaceutical (Holdings) Limited (2348.HK)
HKD 1.16
(0.0%)
HKD 1.16
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -785.29 Million CNY | 2.24% |
| 2022 | -803.27 Million CNY | -44.94% |
| 2021 | -554.22 Million CNY | 23.87% |
| 2020 | -728.03 Million CNY | -189.16% |
| 2019 | -251.77 Million CNY | 60.99% |
| 2018 | -645.36 Million CNY | -5.61% |
| 2017 | -611.07 Million CNY | 6.59% |
| 2016 | -654.19 Million CNY | 3.36% |
| 2015 | -676.94 Million CNY | -37.93% |
| 2014 | -490.77 Million CNY | -1257.36% |
| 2013 | 42.4 Million CNY | 137.14% |
| 2012 | -114.16 Million CNY | -1002.26% |
| 2011 | 12.65 Million CNY | 107.92% |
| 2010 | -159.81 Million CNY | -109.83% |
| 2009 | -76.16 Million CNY | -442.93% |
| 2008 | -14.02 Million CNY | 81.74% |
| 2007 | -76.84 Million CNY | -74.55% |
| 2006 | -44.02 Million CNY | -28.26% |
| 2005 | -34.32 Million CNY | 65.11% |
| 2004 | -98.38 Million CNY | 26.86% |
| 2003 | -134.52 Million CNY | -224.34% |
| 2002 | -41.47 Million CNY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 Q2 | -707.69 Million CNY | 0.0% |
| 2023 FY | -785.29 Million CNY | 2.24% |
| 2023 Q4 | -785.29 Million CNY | 0.0% |
| 2022 Q2 | -575.25 Million CNY | 0.0% |
| 2022 Q4 | -803.27 Million CNY | 0.0% |
| 2022 FY | -803.27 Million CNY | -44.94% |
| 2021 Q4 | -554.22 Million CNY | 0.0% |
| 2021 FY | -554.22 Million CNY | 23.87% |
| 2021 Q2 | -560.04 Million CNY | 0.0% |
| 2020 Q2 | -420.29 Million CNY | 0.0% |
| 2020 FY | -728.03 Million CNY | -189.16% |
| 2020 Q4 | -728.03 Million CNY | 0.0% |
| 2019 Q4 | -251.77 Million CNY | 0.0% |
| 2019 Q2 | -244.5 Million CNY | 0.0% |
| 2019 FY | -251.77 Million CNY | 60.99% |
| 2018 Q4 | -645.36 Million CNY | 0.0% |
| 2018 Q2 | -594.84 Million CNY | 0.0% |
| 2018 FY | -645.36 Million CNY | -5.61% |
| 2017 FY | -611.07 Million CNY | 6.59% |
| 2017 Q2 | -534.45 Million CNY | 0.0% |
| 2017 Q4 | -611.07 Million CNY | 0.0% |
| 2016 Q4 | -654.19 Million CNY | 0.0% |
| 2016 Q2 | -757.33 Million CNY | 0.0% |
| 2016 FY | -654.19 Million CNY | 3.36% |
| 2015 Q4 | -676.94 Million CNY | 0.0% |
| 2015 FY | -676.94 Million CNY | -37.93% |
| 2015 Q2 | -428.24 Million CNY | 0.0% |
| 2014 Q2 | -115.64 Million CNY | 0.0% |
| 2014 FY | -490.77 Million CNY | -1257.36% |
| 2014 Q4 | -490.77 Million CNY | 0.0% |
| 2013 Q2 | 39.21 Million CNY | 0.0% |
| 2013 FY | 42.4 Million CNY | 137.14% |
| 2013 Q4 | -214.71 Million CNY | 0.0% |
| 2012 Q4 | -114.16 Million CNY | 0.0% |
| 2012 FY | -114.16 Million CNY | -1002.26% |
| 2012 Q2 | 41.62 Million CNY | 0.0% |
| 2011 Q2 | 29.51 Million CNY | 0.0% |
| 2011 FY | 12.65 Million CNY | 107.92% |
| 2011 Q4 | 12.65 Million CNY | 0.0% |
| 2010 FY | -159.81 Million CNY | -109.83% |
| 2010 Q2 | -118.83 Million CNY | 0.0% |
| 2010 Q4 | -159.81 Million CNY | 0.0% |
| 2009 FY | -76.16 Million CNY | -442.93% |
| 2009 Q4 | -76.16 Million CNY | 0.0% |
| 2009 Q2 | -29.53 Million CNY | 0.0% |
| 2008 FY | -14.02 Million CNY | 81.74% |
| 2008 Q4 | -14.02 Million CNY | 0.0% |
| 2007 FY | -76.84 Million CNY | -74.55% |
| 2006 FY | -44.02 Million CNY | -28.26% |
| 2005 FY | -34.32 Million CNY | 65.11% |
| 2004 FY | -98.38 Million CNY | 26.86% |
| 2003 FY | -134.52 Million CNY | -224.34% |
| 2002 FY | -41.47 Million CNY | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Pak Fah Yeow International Limited | -258.7 Million HKD | -203.552% |
| Grand Pharmaceutical Group Limited | 2.03 Billion HKD | 138.649% |
| Extrawell Pharmaceutical Holdings Limited | 5.94 Million HKD | 13311.625% |
| Wai Yuen Tong Medicine Holdings Limited | 301.53 Million HKD | 360.433% |
| Qianhai Health Holdings Limited | -19.03 Million HKD | -4024.903% |
| Lee's Pharmaceutical Holdings Limited | 30.94 Million HKD | 2637.479% |
| Essex Bio-Technology Limited | -219.22 Million HKD | -258.209% |
| Tongfang Kontafarma Holdings Limited | 256.16 Million HKD | 406.561% |
| PuraPharm Corporation Limited | 377.54 Million HKD | 307.999% |
| SSY Group Limited | 1.71 Billion HKD | 145.829% |
| JBM (Healthcare) Limited | -7.39 Million HKD | -10513.583% |
| Jacobson Pharma Corporation Limited | 337.44 Million HKD | 332.721% |
| China Resources Pharmaceutical Group Limited | 50.97 Billion HKD | 101.54% |